Table 1.
Descriptive characteristics
| Characteristic | Overall sample (N = 133) | Endorsed suicide risk | |
|---|---|---|---|
| PHQ-9, item 9 (n = 13) | C-SSRS (n = 15) | ||
| Age (years) | 19.6 ± 1.1; 16, 22 | 20.0 ± 1.2; 17.5, 21.3 | 20.1 ± 1.1; 17.5, 21.3 |
| Female sex | 68 (51.1) | 8 (61.5) | 9 (60.0) |
| Race | |||
| White | 99 (74.4) | 9 (69.2) | 11 (73.3) |
| Black | 9 (6.8) | 3 (23.1) | 2 (13.3) |
| Asian | 3 (2.2) | 0 (0) | 1 (6.7) |
| Multiracial | 6 (4.5) | 1 (7.7) | 0 (0) |
| Other | 12 (9.0) | 0 (0) | 1 (6.7) |
| Unknown/not reported | 4 (3.0) | 0 (0) | 0 (0) |
| Ethnicity | |||
| Non-Hispanic/Latino | 116 (87.2) | 13 (100.0) | 15 (100.0) |
| Hispanic/Latino | 12 (9.0) | 0 (0) | 0 (0) |
| Unknown/not reported | 5 (3.8) | 0 (0) | 0 (0) |
| Preferred language of care | |||
| English | 125 (94.0) | 13 (100.0) | 14 (93.3) |
| Spanish | 1 (0.8) | 0 (0) | 0 (0) |
| Other | 3 (2.2) | 0 (0) | 1 (6.7) |
| Unknown/not reported | 4 (3.0) | 0 (0) | 0 (0) |
| Type 1 diabetes characteristics | |||
| Age at diagnosis (years) | 9.8 ± 4.3; 0.5, 18.5 | 9.1 ± 5.2; 0.5, 15.6 | 9.5 ± 4.9; 1.4, 16.4 |
| Duration (years) | 9.7 ± 4.3, 1.0, 19.7 | 10.8 ± 5.0; 4.4, 20.0 | 10.6 ± 4.9; 1.8, 19.4 |
| Insulin delivery method | |||
| Multiple daily injections | 56 (42.1) | 8 (61.5) | 8 (53.3) |
| Pump | 74 (55.6) | 5 (38.5) | 6 (40.0) |
| CGM prescription | 75 (56.4) | 5 (38.5) | 7 (46.7) |
| HbA1c | 8.7 ± 2.0; 5.4, <14 | 9.8 ± 2.4; 7.0, 13.9 | 9.3 ± 1.9; 6.9, 13.2 |
Data are reported as n (%) or mean ± SD; minimum, maximum. CGM, continuous glucose monitor.